Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Revenue

Maze Therapeutics had revenue of $20.00M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $20.00M, down -88.06% year-over-year.

• Revenue (ttm): $20.00M
• Revenue Growth: -88.06%
• P/S Ratio: 73.14
• Revenue / Employee: $141,844
• Employees: 141
• Market Cap: 1.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	167.50M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error